FUTURA MEDICAL DEVELOPMENTS LIMITED

• ⚠

  Material uncertainty over going concern

  The Directors believe that it remains appropriate to prepare the financial statements on a going concern basis. However, they also acknowledge that a material uncertainty exists that may cast significant doubt on the Company's ability to generate sufficient net revenues and resulting cash inflows and raise sufficient finance to meet its expected costs to discharge its liabilities in the normal course of business. The Board does not believe that the Company's position at this point in the execution of its strategy is unusual. However, should the forecast revenue (in particular, royalty receipts and milestone receipts) not be achieved, the Company may require further funding, in excess of what is currently held by its parent company, within the going concern assessment period. As such funding is not committed, this indicates the existence of a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern and, therefore, they may be unable to realise its assets and discharge their liabilities in the normal course of business.

1. FUTURA MEDICAL DEVELOPMENTS LIMITED 2001-07-11 → present
2. FUTURA MEDICAL LIMITED 1997-10-27 → 2001-07-11

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Directors believe that it remains appropriate to prepare the financial statements on a going concern basis. However, they also acknowledge that a material uncertainty exists that may cast significant doubt on the Company's ability to generate sufficient net revenues and resulting cash inflows and raise sufficient finance to meet its expected costs to discharge its liabilities in the normal course of business. The Board does not believe that the Company's position at this point in the execution of its strategy is unusual. However, should the forecast revenue (in particular, royalty receipts and milestone receipts) not be achieved, the Company may require further funding, in excess of what is currently held by its parent company, within the going concern assessment period. As such funding is not committed, this indicates the existence of a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern and, therefore, they may be unable to realise its assets and discharge their liabilities in the normal course of business.”

Group structure

1. FUTURA MEDICAL DEVELOPMENTS LIMITED · parent
   1. Futura Consumer Healthcare Limited 100% · England and Wales · dormant

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +349.1%

  £3,100,968 → £13,926,122

• Cash

  +23.4%

  £3,757,262 → £4,635,155

• Net assets

  +337.3%

  £1,651,592 → £7,222,089

• Employees

  +16.7%

  12 → 14

• Operating profit

  +131.5%

  -£6,365,471 → £2,004,674

• Profit before tax

  +132.3%

  -£6,329,949 → £2,044,051

• Wages

  +3.4%

  £2,284,686 → £2,361,556

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers